Lexeo Therapeutics earnings were -$109.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LXEO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$32.7M, up 26% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LXEO reported annual earnings of -$98.3M, with 48.1% growth. The next LXEO earnings date is Aug 18, 2025.
What were Lexeo Therapeutics's earnings last quarter?
Lexeo Therapeutics (NASDAQ: LXEO) reported Q1 2025 earnings per share (EPS) of -$0.99, up 28.57% year over year. Total LXEO earnings for the quarter were -$32.66 million. In the same quarter last year, Lexeo Therapeutics's earnings per share (EPS) was -$0.77.
The next LXEO earnings call is Invalid Date. Add LXEO to your watchlist to be reminded of Lexeo Therapeutics's next earnings date.
Is Lexeo Therapeutics profitable or losing money?
As of the last Lexeo Therapeutics earnings report, Lexeo Therapeutics is currently losing money. Lexeo Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$109.31 million, a 57.46% increase year over year.
What was LXEO's earnings growth in the past year?
As of Lexeo Therapeutics's earnings date in Q3 2025, Lexeo Therapeutics's earnings has grown year over year. LXEO earnings in the past year totalled -$109.31 million.
What are Lexeo Therapeutics's earnings expectations?
The current EPS estimate for Lexeo Therapeutics's earnings report in Invalid Date is -$0.91.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.